Abbott (ABT) Reports In-Line Q4 EPS; offers guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/6/2026

1. MRVL
2. USO
3. SPY
4. BBIO
5. NVDA
6. OPCH
7. GOOGL
8. AMD
9. CHRW
10. NEOG

Go back to Abbott (ABT) Reports In-Line Q4 EPS; offers guidance

Abbott Labs (ABT) PT Raised to $140 at BTIG

January 22, 2025 1:54 PM EST

BTIG analyst Marie Thibault raised the price target on Abbott Labs (NYSE: ABT) to $140.00 (from $139.00) while maintaining a Buy rating.

The analyst comments "Abbott reported a Q4 total revenue miss, much of which we attribute to greater Fx headwinds and lower-than-expected COVID testing revenue, and adj. EPS in line with expectations (see our flash note here). In our view, the main message on the call was the positive 2025 outlook, which called for above-consensus organic sales growth, a return to DD adj. EPS growth, and an impressive 150 bps of... More